Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 102 of 124)
- Relevance
  Sort by

CAR-T - Pipeline Insight, 2024

 Clinical Trials
June 2024
450 Pages
Global

From

€3432EUR$3,500USD£2,860GBP

€4903EUR$5,000USD£4,085GBP

Neuroendocrine Tumor Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Product Analysis, By Site Analysis, By End User, By Region and Competition

 Report
March 2023
117 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Cancer Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€2574EUR$2,625USD£2,145GBP

€3677EUR$3,750USD£3,064GBP

Cancer Immunotherapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€2574EUR$2,625USD£2,145GBP

€3677EUR$3,750USD£3,064GBP

Hematological Cancer (Blood Cancer) Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€2574EUR$2,625USD£2,145GBP

€3677EUR$3,750USD£3,064GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cancer Immunotherapy Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
January 2024
150 Pages
Global

From

€4756EUR$4,850USD£3,963GBP

Europe Soft Tissue Sarcoma Market By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drug, Radiation Therapy), By Disease Type, By End User, By Country, Competition, Forecast & Opportunities, 2028

 Report
April 2023
86 Pages
Europe

From

€3922EUR$4,000USD£3,268GBP

Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer, and Others), By Indication, By End User, By Region, and Competition

 Report
March 2023
113 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Stomach Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Treatment Type, By Cancer Type, By Route of Administration, By Drug Class, By Distribution Channel, By Region and Competition

 Report
March 2023
112 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Elbow Stiffness Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2023
116 Pages
Global

From

€3500EUR$3,823USD£3,018GBP

CXCR4 Inhibitor - Pipeline Insight, 2024

 Clinical Trials
January 2024
90 Pages
Global

From

€1030EUR$1,050USD£858GBP

€1471EUR$1,500USD£1,226GBP

Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2024

 Clinical Trials
January 2024
90 Pages
Global

From

€1030EUR$1,050USD£858GBP

€1471EUR$1,500USD£1,226GBP

$Checkpoint Inhibitor Refractory Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image$

Checkpoint Inhibitor Refractory Cancer - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5457EUR$5,565USD£4,547GBP

€7796EUR$7,950USD£6,496GBP

HER2+ Gastric Cancer - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5457EUR$5,565USD£4,547GBP

€7796EUR$7,950USD£6,496GBP

Soft Tissue Sarcoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5457EUR$5,565USD£4,547GBP

€7796EUR$7,950USD£6,496GBP

Osteosarcoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5457EUR$5,565USD£4,547GBP

€7796EUR$7,950USD£6,496GBP

Orphan Drugs Market 2023-2027

 Report
March 2023
171 Pages
Global

From

€2451EUR$2,500USD£2,043GBP

Gastrointestinal Stromal Tumors - Pipeline Insight, 2024

 Clinical Trials
April 2024
85 Pages
Global

From

€1373EUR$1,400USD£1,144GBP

€1961EUR$2,000USD£1,634GBP

Malignant Pleural Mesothelioma - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1373EUR$1,400USD£1,144GBP

€1961EUR$2,000USD£1,634GBP

Idiopathic Pulmonary Fibrosis Market by Drug Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030

 Report
January 2022
169 Pages
Global

From

€3640EUR$3,712USD£3,033GBP

2,461 Results (Page 102 of 124)
- 1
- 100
- 101
- 102
- 103
- 104

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.